7 
 
 
Fig.2 Comparison of Pearson correlation Coefficient obtained on S461 dataset between the original 
method (pink bar) and its adjusted version with Mass-Balance Correction, using bothMBC(dd) (green 
bar) and Rose scale (blue bar). ddMMBC_only represents the prediction made using only the fitted 
mutation coefficients without incorporating a method.  *KD25 and *Rose26  and are the scale difference 
values without any fitting. 
 
Generalization of the Mass-Balance Correction Across Different Methods 
 
Reeves and Kalyaanamoorthy30 recently highlighted that structure-based and 
sequence-based PLMs can be linearly combined to improve the performance, 
indicating that these two methodological classes provide complementary information. 
They further noted that â€œ...PSLMs can be reliably augmented with physicochemical 
properties to exceed the median performance of the benchmark stability predictor..â€. 
This aligns with our model, since 
 
ğ›¥ğ›¥ğº= (ğºğ¹(ğ‘š) âˆ’ğºğ¹(ğ‘¤)) âˆ’(ğºğ‘ˆ(ğ‘š) âˆ’ğºğ‘ˆ(ğ‘¤)) = ğ›¥ğ›¥ğ»ğ¹âˆ’ğ‘‡ğ›¥ğ›¥ğ‘†ğ¹  
 
[5] 
 
Thus, it is reasonable to think that both sequence and structure-based terms 
correspond to the Î”Î”G term for the unfolded and folded states, respectively.  
Additionally, the molecular volume and the solvent-accessible surface area (SASA) 
play a crucial role in estimating the solvation energy changes (a large part of Î”Î”Sğ¹) 
when a molecule interacts with a solvent. This concept has been widely applied in 
different implicit solvation models, such as the GBSA family of models31,32.  
From this perspective, the MBC can be seen as a proxy of this information. Our 
model provides a simple, yet effective, way to estimate the Gibbs free energy 
difference between wild-type and mutated proteins in their unfolded states. 
